MENU
TRDA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Entrada Therapeutics (TRDA) Ownership - Who owns Entrada Therapeutics?

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

Profile

Industry
N/A
Address
One Design Center Place
Phone
+1 857 520-9158
Employees
159
Web
https://www.entradatx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
404.36M
P/E Ratio
10.26
Total Cash
326.84M
Projected Growth
N/A
Total Debt
52.4M
Revenue
61.52M
Risk (Beta)
0.83
Dividend Yield
N/A
Total Cash/Share
8.55
Total Debt/Equity
N/A
Revenue/Share
1.47 USD as % of share price

Fundamentals

TRDA
Capitalization
404M
P/E Ratio
10.26
Risk (Beta)
0.83
Dividend Yield
N/A
Total Cash
327M
Total Cash/Share
8.55
Total Debt
52.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.47%
Revenue
61.5M
ROE
N/A
Book Value
341M
P/B Ratio
1.19
Cash Flow
N/A
Earnings
-2.56
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
14.08
Current Revenue Per Employee
8819.67
Dividends Per Share - Security
N/A
EBITDA
-117.36M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-21.39
Shares Held By Institutions
209M
Shares Outstanding - Current
38.2M
Total Liabilities
72.2M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-38.809
View a ticker or compare two or three
TRDA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TRDA showed earnings on November 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
One Design Center Place
Phone
+1 857 520-9158
Employees
159
Web
https://www.entradatx.com